- Home
- ORC vs ORIC Comparison
ORC vs ORIC Comparison
Compare ORC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- ORIC
- Stock Information
- Founded
- ORC 2010
- ORIC 2014
- Country
- ORC United States
- ORIC United States
- Employees
- ORC N/A
- ORIC N/A
- Industry
- ORC Real Estate Investment Trusts
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- ORIC Health Care
- Exchange
- ORC Nasdaq
- ORIC Nasdaq
- Market Cap
- ORC 660.1M
- ORIC 362.9M
- IPO Year
- ORC 2013
- ORIC 2020
- Fundamental
- Price
- ORC $7.03
- ORIC $10.85
- Analyst Decision
- ORC Hold
- ORIC Strong Buy
- Analyst Count
- ORC 3
- ORIC 9
- Target Price
- ORC N/A
- ORIC $18.29
- AVG Volume (30 Days)
- ORC 3.8M
- ORIC 932.0K
- Earning Date
- ORC 07-24-2025
- ORIC 08-11-2025
- Dividend Yield
- ORC 20.51%
- ORIC N/A
- EPS Growth
- ORC N/A
- ORIC N/A
- EPS
- ORC 0.46
- ORIC N/A
- Revenue
- ORC $52,240,000.00
- ORIC N/A
- Revenue This Year
- ORC $46.17
- ORIC N/A
- Revenue Next Year
- ORC $26.45
- ORIC N/A
- P/E Ratio
- ORC $15.31
- ORIC N/A
- Revenue Growth
- ORC N/A
- ORIC N/A
- 52 Week Low
- ORC $5.69
- ORIC $3.90
- 52 Week High
- ORC $9.01
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- ORC 46.51
- ORIC 61.82
- Support Level
- ORC $7.10
- ORIC $10.72
- Resistance Level
- ORC $7.28
- ORIC $11.45
- Average True Range (ATR)
- ORC 0.11
- ORIC 0.58
- MACD
- ORC -0.00
- ORIC -0.08
- Stochastic Oscillator
- ORC 32.89
- ORIC 57.65
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.